Eden and Zepbound: Compounded Tirzepatide via Telehealth

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub: what "Eden Zepbound" involves, including the difference between the branded drug and the compounded tirzepatide telehealth typically supplies. Browse the Peptides & GLP-1 hub

Full head-to-head: PlexusDx vs Eden →

This is an independent editorial review. PlexusDx has no affiliation, paid partnership, or commercial relationship with Eden, its parent company, or the makers of Zepbound.

Zepbound is a specific brand of tirzepatide, so "Eden Zepbound" searches usually come down to one question: does Eden supply that brand, or a compounded version of the same molecule? This review answers that and outlines the telehealth model, fair-balance and not as a recommendation. Eden figures verified at checkout, July 2026.

Zepbound vs compounded tirzepatide at Eden

Zepbound is a brand name for tirzepatide, an FDA-approved finished product. Telehealth programs like Eden generally dispense compounded tirzepatide from a 503A pharmacy rather than the branded drug. The active dual-agonist molecule is identical, but a branded finished product and a compounded preparation are different regulatory items — the key thing to understand when a search says "Zepbound" but a program supplies compounded tirzepatide.

What Eden telehealth delivers for tirzepatide seekers

Eden combines licensed telehealth with a compounding pharmacy. You complete an online intake, a clinician reviews it, and an approved prescription for compounded tirzepatide is fulfilled as an injection, with follow-up for titration. Eden does not market a branded Zepbound product and offers no oral tirzepatide. Check current availability at Eden's official website.

The compounded-pharmacy (503A) route explained

A 503A compounding pharmacy prepares medication for an individual patient against a prescription. Compounded tirzepatide made this way is not an FDA-approved finished drug product — the central distinction from branded Zepbound. Telehealth brands rely on the compounded route mainly to keep cash-pay pricing accessible. The molecule is the same dual GIP/GLP-1 agonist; the regulatory pathway is what changes.

Eden's cost for the tirzepatide program

Eden advertises $199 per month for compounded tirzepatide (medication only). A required Eden Membership adds $99 per month, so the true cost is $298 all-in per month. Billing is monthly and injection-only, with nothing charged until approval and a 10%-in-six-months money-back warranty. PlexusDx Tirzepatide Injection is $289 month to month, with Tirzepatide Oral at $349 — a format Eden does not carry.

What the SURMOUNT trials established

Tirzepatide's weight-management evidence comes chiefly from the SURMOUNT program in The New England Journal of Medicine (2022), with SURMOUNT-OSA addressing obstructive sleep apnea in 2024. Semaglutide's STEP trials (2021) provide a GLP-1 comparator. Trial doses, populations, and endpoints differ from compounded telehealth practice, and individual results vary.

The genomic variable behind every Zepbound decision

Branded or compounded, tirzepatide meets a metabolism it cannot read on its own. TCF7L2 connects to glucose control and incretin signaling, GLP1R codes for one of the two receptors tirzepatide binds, while FTO and MC4R govern fat mass and appetite. These pathway-level variants do not predict response to Zepbound or any compound, but they map the biology behind the decision. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, and pairs with the PlexusDx Weight Management Protocols.

No affiliation: PlexusDx is not affiliated with Eden or the makers of Zepbound and has no commercial relationship with any brand named in this article.

More from PlexusDx: Compounded Zepbound, Generic Zepbound, How to Get Zepbound, Injection Zepbound.

Educational only. PlexusDx is not affiliated with Eden or the makers of Zepbound and compares tirzepatide approaches across GLP-1 telehealth, including its own Weight Management Protocols. The Precision Peptide Genetic Test reports how genes influence peptide-related pathways and does not predict response to any medication. Consult a qualified healthcare provider before starting a protocol.

Consider the alternative: the PlexusDx Weight Management Protocols offer month-to-month tirzepatide in injection and oral formats, or take the Precision Peptide Genetic Test to read your metabolic pathway first.

This Zepbound overview is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Frequently Asked Questions

Does Eden sell Zepbound?

Eden does not market its offering as branded Zepbound. Programs in its model generally dispense compounded tirzepatide from a 503A pharmacy instead of the branded finished product. If you specifically want branded Zepbound, confirm availability directly on the brand's own site before enrolling.

Is compounded tirzepatide the same as Zepbound?

Both contain the tirzepatide molecule, but Zepbound is an FDA-approved finished drug while compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual patient and is not an FDA-approved finished product. The regulatory status and supply differ; the active dual agonist does not.

What does Eden charge for compounded tirzepatide?

Eden lists $199 monthly for the tirzepatide medication, then requires a $99 membership on top of it. The all-in figure is therefore $298 per month. Charges begin only once a provider approves, and every plan bills month to month.

Can a genetic test predict my Zepbound results?

No. The Precision Peptide Genetic Test does not predict response to Zepbound or any compound. It reports pathway-level variants such as TCF7L2 that describe baseline metabolic biology — context for a discussion with your provider, not a forecast of outcomes.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.